Although TB affects more than eight-million people worldwide the current vaccine is only marginally effective and it's not even used in the US.
After testing the new vaccine on a group of South African infants researchers say it was no better than a placebo in preventing new cases or stopping the progressions of existing infections.
Experts say although the vaccine does not protect babies from TB it might possibly benefit adolescents and adults.
TXT 24
Twitter
Facebook